Wordt geladen...
FLT3 Inhibition and Mechanisms of Drug Resistance in mutant FLT3-Positive AML
An appealing therapeutic target for AML is constitutively-activated, mutant FLT3, which is expressed in a subpopulation of AML patients and is generally a poor prognostic indicator in patients under the age of 65. There are currently several FLT3 inhibitors that are undergoing clinical investigation...
Bewaard in:
| Gepubliceerd in: | Drug Resist Updat |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2009
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4472331/ https://ncbi.nlm.nih.gov/pubmed/19467916 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drup.2009.04.001 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|